-
How has Ocrevus effected your life?
Genentech’s Ocrevus (ocrelizumab) was approved by U.S. regulators a little over a year ago as the first treatment for both progressive and relapsing forms of MS.
While the therapy’s long term effectiveness and safety remain to be seen, we spoke to five MS patients across the country who say Ocrevus has made a dramatic difference in their daily lives.
Read these patients stories here: “5 MS Patients Across US Talk About How Ocrevus Has Changed Their Lives”
And share your own story with us!
-
0 Replies
Sorry, there were no replies found.
Log in to reply.